Agreement - August 30, 2024
Rokote Laboratories signs an agreement with 3PBIOVIAN
Rokote Laboratories Finland has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2. 3PBIOVIAN will provide Rokote Laboratories with Drug Substance and Drug Product to bring the intranasal FINCoVac 2.1 vaccine into Phase I clinical studies. The […]
Collaboration - August 27, 2024
The next expansion phase of Oslo Cancer Cluster Innovation Park
An agreement has been signed between Oslo City Council and Oslo Science Hub to sell the lots necessary for the planned building that will transform the Oslo Montebello area into an international power centre for cancer research. “Our vision is to create a vital and inclusive environment where researchers, entrepreneurs and companies at the Radium […]
Agreement - August 22, 2024
Oblique in agreement with Eli Lilly and Company
The Swedish biotech company has entered into a research collaboration agreement with Eli Lilly and Company to apply its AbiProt technology to generate antibodies against a well-validated target protein. This partnership aims to accelerate research and development of innovative treatments and, if successful, will generate milestone payments and royalty income, states the company. Under the […]
Collaboration - July 10, 2024
Multi-faceted action and a comprehensive nationwide strategy
Obesity is a chronic disease that requires continuous interdisciplinary research to find and develop effective new tools for prevention and treatment. NLS asked the Finnish Association for the Study of Obesity (FASO) about the Nordic region’s challenges and efforts within obesity. How would you describe the impact that drugs like semaglutide have had on obesity […]
Collaboration - July 10, 2024
Multi-faceted action and a comprehensive nationwide strategy
Obesity is a chronic disease that requires continuous interdisciplinary research to find and develop effective new tools for prevention and treatment. NLS asked the Finnish Association for the Study of Obesity (FASO) about the Nordic region’s challenges and efforts within obesity. How would you describe the impact that drugs like semaglutide have had on obesity […]
Collaboration - July 9, 2024
West Sweden’s life science community takes leading role in PRECISEU
Sahlgrenska Science Park and Business Region Göteborg (BRG), in collaboration with Region Västra Götaland and Sahlgrenska University Hospital, have taken leading roles in the PRECISEU project. This European initiative aims to connect innovation ecosystems across Europe to efficiently advance towards truly personalized healthcare. The PRECISEU project is designed to transfer best practices and solutions across […]
